Form 8-K - Current report:
SEC Accession No. 0001193125-22-212487
Filing Date
2022-08-04
Accepted
2022-08-04 16:02:03
Documents
13
Period of Report
2022-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d249846d8k.htm   iXBRL 8-K 31082
2 EX-99.1 d249846dex991.htm EX-99.1 82882
  Complete submission text file 0001193125-22-212487.txt   251873

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cris-20220804.xsd EX-101.SCH 2850
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cris-20220804_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cris-20220804_pre.xml EX-101.PRE 11257
7 EXTRACTED XBRL INSTANCE DOCUMENT d249846d8k_htm.xml XML 3398
Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30347 | Film No.: 221136377
SIC: 2836 Biological Products, (No Diagnostic Substances)